Investigating the Role of Sodium-glucose Cotransporter-2 Inhibitors in Slowing Down the Diabetic Kidney Disease Progression: A Meta-analysis of Randomized Control Trials

Publications Category : Nephrology

Author(s): Ayesha Saleem, Shahroz M. Khan, Imdad Ullahc, Syed S. Nasim, Sajedur Rahman, Arslan Tayyab

Project Description : The one of most common and severe complications is diabetic kidney disease, which leads to in the long term. However, there are many recent developments in medical therapy, especially when we use inhibitors SGLT2, which always gives us the best outcome in improving patient compliance and reducing the higher risk of mortality which is associated with the long-run consequences of diabetic metabolic control. This comprehensive systematic review delves into the efficacy of SGLT2 inhibitors which have capacity to slow down the progression rate of diabetes kidney disorder.